Korea Stock Market Insights

Tag: IBIM Technology

  • IBIM Technology Secures $375K Biomicroscope Supply Contract: Investment Analysis



    IBIM Technology Secures $375K Biomicroscope Supply Contract: Investment Analysis 대표 차트 이미지






    What Happened?

    On September 10, 2025, IBIM Technology announced a $375,000 biomicroscope supply contract with Revvity (HONGKONG) LIMITED. The contract period is two months, and the supply region is China. This represents 12.92% of IBIM Technology’s sales.

    Why Does This Contract Matter?

    This contract not only directly impacts short-term sales growth but also signifies securing a new partner in the Chinese market. This is particularly positive for IBIM Technology, which has been seeking new opportunities after the agency change issue in China in 2024. It also reaffirms the company’s technology and market competitiveness.

    So, What About the Stock Price?

    While there might be a positive short-term impact on the stock price, the effect could be limited. The fundamental issues of continuous losses and sluggish sales remain unresolved. The mid-to-long-term stock performance depends on securing larger contracts, new technology development achievements, and, most importantly, actual performance improvement.

    What Should Investors Do?

    • Monitor contract implementation: Verify if the contract proceeds as planned and leads to further orders.
    • Check for performance improvement trends: Pay close attention to profitability improvements.
    • Watch for new large-scale contract announcements: This is a crucial indicator of the company’s growth potential.
    • Evaluate technology development and market competitiveness: Critical factors for long-term investment.
    • Consider macroeconomic indicator volatility: Assess the impact of fluctuations in exchange rates, interest rates, etc.


    Frequently Asked Questions (FAQ)

    Will this contract turn IBIM Technology profitable?

    While this contract is positive, it’s unlikely to single-handedly lead to profitability. Continuous efforts to improve profitability are necessary.

    What is IBIM Technology?

    IBIM Technology possesses the world’s first all-in-one biomicroscope platform technology and offers innovative solutions utilized in life science research and new drug development.

    What precautions should investors take?

    IBIM Technology is currently experiencing continuous losses and exhibits high stock price volatility. Investments should be made after comprehensively considering the company’s financial status, growth strategy, and market competition.









    IBIM Technology Secures $375K Biomicroscope Supply Contract: Investment Analysis 관련 이미지
    IBIM Technology Secures $375K Biomicroscope Supply Contract: Investment Analysis 관련 이미지




  • IBIM Technology (460470) H1 2025 Earnings Analysis: Growth vs. Profitability

    1. What Happened at IBIM Technology?

    IBIM Technology reported revenue of KRW 87.18 billion in H1 2025, a 7.8% increase year-over-year. Growth was driven by strong performance in the live cell imaging and CRO service segments. However, operating losses widened to KRW 27.05 billion.

    2. Why the Growth and Widening Losses?

    The revenue growth reflects the success of IBIM Technology’s innovative AI-based tissue analysis technology and global market expansion efforts. The widening operating loss is attributed to continued R&D investment and increased sales and administrative expenses.

    3. What’s the Outlook?

    IBIM Technology has significant growth potential, fueled by its cutting-edge technology. However, persistent operating losses remain a concern for investors. Future stock performance will hinge on tangible R&D achievements, global market penetration, and efficient cost management to improve profitability. Currently, the stock is trading near its IPO price, and high volatility is expected.

    4. What Should Investors Do?

    • Short-term investors: Carefully monitor profitability improvements and strategically time investments.
    • Long-term investors: Focus on the company’s ability to secure market dominance and generate profits through technological innovation, considering a long-term investment horizon.
    What are IBIM Technology’s core technologies?

    IBIM Technology possesses unique core technologies, including AI-based tissue analysis medical devices and high-speed laser scanning.

    How did IBIM Technology perform in H1 2025?

    The company reported KRW 87.18 billion in revenue (up 7.8% YoY) and an operating loss of KRW 27.05 billion (increased YoY).

    What is the outlook for IBIM Technology’s stock price?

    Currently trading near its IPO price, the stock is expected to be highly volatile, depending on future earnings improvements and technological advancements.